TY  - JOUR
AU  - Linhares, Yuliya
AU  - Kaganski, Alexander
AU  - Agyare, Christian
AU  - Kurnaz, Isil A.
AU  - Neergheen, Vidushi
AU  - Kolodziejczyk, Bartlomiej
AU  - Kędra, Monika
AU  - Wahajuddin, Muhammad
AU  - El-Youssf, Lahcen
AU  - de la Cruz, Thomas Eddison
AU  - Baran, Yusuf
AU  - Pešić, Milica
AU  - Shrestha, Uttam
AU  - Bakiu, Rigers
AU  - Allard, Pierre-Marie
AU  - Rybtsov, Stanislav
AU  - Pieri, Myrtani
AU  - Siciliano, Velia
AU  - Flores Bueso, Yensi
PY  - 2022
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5337
AB  - Biodiversity is the measure of the variation of lifeforms in a given ecological system. Biodiversity provides ecosystems with the robustness, stability, and resilience that sustains them. This is ultimately essential for our survival because we depend on the services that natural ecosystems provide (food, fresh water, air, climate, and medicine). Despite this, human activity is driving an unprecedented rate of biodiversity decline, which may jeopardize the life-support systems of the planet if no urgent action is taken. In this article we show why biodiversity is essential for human health. We raise our case and focus on the biomedicine services that are enabled by biodiversity, and we present known and novel approaches to promote biodiversity conservation.
PB  - Oxford, UK : Elsevier Science Ltd.
T2  - Trends in Molecular Medicine
T1  - Biodiversity: the overlooked source of human health
DO  - 10.1016/j.molmed.2022.12.002
ER  - 

@article{
author = "Linhares, Yuliya and Kaganski, Alexander and Agyare, Christian and Kurnaz, Isil A. and Neergheen, Vidushi and Kolodziejczyk, Bartlomiej and Kędra, Monika and Wahajuddin, Muhammad and El-Youssf, Lahcen and de la Cruz, Thomas Eddison and Baran, Yusuf and Pešić, Milica and Shrestha, Uttam and Bakiu, Rigers and Allard, Pierre-Marie and Rybtsov, Stanislav and Pieri, Myrtani and Siciliano, Velia and Flores Bueso, Yensi",
year = "2022",
abstract = "Biodiversity is the measure of the variation of lifeforms in a given ecological system. Biodiversity provides ecosystems with the robustness, stability, and resilience that sustains them. This is ultimately essential for our survival because we depend on the services that natural ecosystems provide (food, fresh water, air, climate, and medicine). Despite this, human activity is driving an unprecedented rate of biodiversity decline, which may jeopardize the life-support systems of the planet if no urgent action is taken. In this article we show why biodiversity is essential for human health. We raise our case and focus on the biomedicine services that are enabled by biodiversity, and we present known and novel approaches to promote biodiversity conservation.",
publisher = "Oxford, UK : Elsevier Science Ltd.",
journal = "Trends in Molecular Medicine",
title = "Biodiversity: the overlooked source of human health",
doi = "10.1016/j.molmed.2022.12.002"
}

Linhares, Y., Kaganski, A., Agyare, C., Kurnaz, I. A., Neergheen, V., Kolodziejczyk, B., Kędra, M., Wahajuddin, M., El-Youssf, L., de la Cruz, T. E., Baran, Y., Pešić, M., Shrestha, U., Bakiu, R., Allard, P., Rybtsov, S., Pieri, M., Siciliano, V.,& Flores Bueso, Y.. (2022). Biodiversity: the overlooked source of human health. in Trends in Molecular Medicine
Oxford, UK : Elsevier Science Ltd...
https://doi.org/10.1016/j.molmed.2022.12.002

Linhares Y, Kaganski A, Agyare C, Kurnaz IA, Neergheen V, Kolodziejczyk B, Kędra M, Wahajuddin M, El-Youssf L, de la Cruz TE, Baran Y, Pešić M, Shrestha U, Bakiu R, Allard P, Rybtsov S, Pieri M, Siciliano V, Flores Bueso Y. Biodiversity: the overlooked source of human health. in Trends in Molecular Medicine. 2022;.
doi:10.1016/j.molmed.2022.12.002 .

Linhares, Yuliya, Kaganski, Alexander, Agyare, Christian, Kurnaz, Isil A., Neergheen, Vidushi, Kolodziejczyk, Bartlomiej, Kędra, Monika, Wahajuddin, Muhammad, El-Youssf, Lahcen, de la Cruz, Thomas Eddison, Baran, Yusuf, Pešić, Milica, Shrestha, Uttam, Bakiu, Rigers, Allard, Pierre-Marie, Rybtsov, Stanislav, Pieri, Myrtani, Siciliano, Velia, Flores Bueso, Yensi, "Biodiversity: the overlooked source of human health" in Trends in Molecular Medicine (2022),
https://doi.org/10.1016/j.molmed.2022.12.002 . .

TY  - JOUR
AU  - Pešić, Milica
AU  - Egamberdieva, Dilfuza
AU  - Kolodziejczyk, Bart
AU  - Elsässer, Simon J.
AU  - Neergheen, Vidushi S.
AU  - Kagansky, Alexander
PY  - 2020
UR  - https://doi.org/10.1007/s42977-020-00043-3
UR  - https://radar.ibiss.bg.ac.rs/123456789/3877
AB  - This paper aims to help policy makers with a characterization of the intrinsic value of biodiversity and its role as a critical foundation for sustainable development, human health, and well-being. Our objective is to highlight the urgent need to overcome economic, disciplinary, national, cultural, and regional barriers, in order to work out innovative measures to create a sustainable future and prevent the mutual extinction of humans and other species. We emphasize the pervasive neglect paid to the cross-dependency of planetary health, the health of individual human beings and other species. It is critical that social and natural sciences are taken into account as key contributors to forming policies related to biodiversity, conservation, and health management. We are reaching the target date of Nagoya treaty signatories to have accomplished measures to prevent biodiversity loss, providing a unique opportunity for policy makers to make necessary adjustments and refocus targets for the next decade. We propose recommendations for policy makers to explore novel avenues to halt the accelerated global loss of biodiversity. Beyond the critical ecological functions biodiversity performs, its enormous untapped repertoire of natural molecular diversity is needed for solving accelerating global healthcare challenges.
PB  - Akademiai Kiado Rt.
T2  - Biologia Futura
T1  - Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-being
DO  - 10.1007/s42977-020-00043-3
ER  - 

@article{
author = "Pešić, Milica and Egamberdieva, Dilfuza and Kolodziejczyk, Bart and Elsässer, Simon J. and Neergheen, Vidushi S. and Kagansky, Alexander",
year = "2020",
abstract = "This paper aims to help policy makers with a characterization of the intrinsic value of biodiversity and its role as a critical foundation for sustainable development, human health, and well-being. Our objective is to highlight the urgent need to overcome economic, disciplinary, national, cultural, and regional barriers, in order to work out innovative measures to create a sustainable future and prevent the mutual extinction of humans and other species. We emphasize the pervasive neglect paid to the cross-dependency of planetary health, the health of individual human beings and other species. It is critical that social and natural sciences are taken into account as key contributors to forming policies related to biodiversity, conservation, and health management. We are reaching the target date of Nagoya treaty signatories to have accomplished measures to prevent biodiversity loss, providing a unique opportunity for policy makers to make necessary adjustments and refocus targets for the next decade. We propose recommendations for policy makers to explore novel avenues to halt the accelerated global loss of biodiversity. Beyond the critical ecological functions biodiversity performs, its enormous untapped repertoire of natural molecular diversity is needed for solving accelerating global healthcare challenges.",
publisher = "Akademiai Kiado Rt.",
journal = "Biologia Futura",
title = "Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-being",
doi = "10.1007/s42977-020-00043-3"
}

Pešić, M., Egamberdieva, D., Kolodziejczyk, B., Elsässer, S. J., Neergheen, V. S.,& Kagansky, A.. (2020). Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-being. in Biologia Futura
Akademiai Kiado Rt...
https://doi.org/10.1007/s42977-020-00043-3

Pešić M, Egamberdieva D, Kolodziejczyk B, Elsässer SJ, Neergheen VS, Kagansky A. Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-being. in Biologia Futura. 2020;.
doi:10.1007/s42977-020-00043-3 .

Pešić, Milica, Egamberdieva, Dilfuza, Kolodziejczyk, Bart, Elsässer, Simon J., Neergheen, Vidushi S., Kagansky, Alexander, "Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-being" in Biologia Futura (2020),
https://doi.org/10.1007/s42977-020-00043-3 . .

TY  - CHAP
AU  - Johnson, Mari-Vaughn V.
AU  - Shrestha, Uttam Babu
AU  - Neergheen, Vidushi S.
AU  - Kagansky, Alexander
AU  - Pešić, Milica
AU  - Malone, John H.
PY  - 2020
UR  - https://www.sciencedirect.com/science/article/pii/B9780128195413000268
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3844
AB  - Biological diversity sustains humanity. It is the nature of the evolutionary process for biodiversity to wax and wane over time, but biodiversity is currently declining at rates undocumented in human history and anthropogenic activities are the primary drivers of biodiversity losses. A variety of solutions have been proposed as means to protect nature and, more specifically, biodiversity. The book you hold posits an idea that may work: the commodification of nature through the lens of biomedical benefits. It remains to be proven whether our decisions and actions will follow this approach and, more so, whether we can pursue this approach in a sustainable relationship with nature, curbing the ongoing rapid species loss while maximizing medical benefits. The challenges are many, cross-cultural, and span engineering and scientific disciplines. The entire value chain iterating between biodiversity and biomedicine requires significant investments of time, money, and expertise if this endeavor is to work. Briefly, challenges include: (1) discovering and documenting species diversity; (2) cataloging traditional medicines developed from these species, including medicinal preparations (e.g., fermentation, desiccation, etc.); (3) assaying genetic and chemical diversity of natural products; (4) testing promising metabolites and other compounds for medical applicability and efficacy (and in turn developing drugs as appropriate); (5) determining why some conservation efforts succeed and others fail; (6) negotiating policies that incentivize and empower local communities to conserve the diversity in their vicinity, while also enacting policies that protect ecosystems from biopiracy and illicit harvesting and trade; and (7) strengthening and developing policy and institutional frameworks to codify and maintain working solutions. Sustainable solutions that bridge biodiversity to biomedicine may include the adoption of policies that shift paradigms around “ownership” of nature and the ecosystem services humans enjoy from diverse systems. Here we provide a context for the concept of commodifying ecosystem services as natural resources.
PB  - Cambridge (Massachusetts, United States) : Academic Press - Elsevier
T2  - Biodiversity and Biomedicine: Our Future
T1  - Biomedicine: biodiversity’s panacea? Context of commodification
DO  - 10.1016/B978-0-12-819541-3.00026-8
SP  - 525
EP  - 537
ER  - 

@inbook{
author = "Johnson, Mari-Vaughn V. and Shrestha, Uttam Babu and Neergheen, Vidushi S. and Kagansky, Alexander and Pešić, Milica and Malone, John H.",
year = "2020",
abstract = "Biological diversity sustains humanity. It is the nature of the evolutionary process for biodiversity to wax and wane over time, but biodiversity is currently declining at rates undocumented in human history and anthropogenic activities are the primary drivers of biodiversity losses. A variety of solutions have been proposed as means to protect nature and, more specifically, biodiversity. The book you hold posits an idea that may work: the commodification of nature through the lens of biomedical benefits. It remains to be proven whether our decisions and actions will follow this approach and, more so, whether we can pursue this approach in a sustainable relationship with nature, curbing the ongoing rapid species loss while maximizing medical benefits. The challenges are many, cross-cultural, and span engineering and scientific disciplines. The entire value chain iterating between biodiversity and biomedicine requires significant investments of time, money, and expertise if this endeavor is to work. Briefly, challenges include: (1) discovering and documenting species diversity; (2) cataloging traditional medicines developed from these species, including medicinal preparations (e.g., fermentation, desiccation, etc.); (3) assaying genetic and chemical diversity of natural products; (4) testing promising metabolites and other compounds for medical applicability and efficacy (and in turn developing drugs as appropriate); (5) determining why some conservation efforts succeed and others fail; (6) negotiating policies that incentivize and empower local communities to conserve the diversity in their vicinity, while also enacting policies that protect ecosystems from biopiracy and illicit harvesting and trade; and (7) strengthening and developing policy and institutional frameworks to codify and maintain working solutions. Sustainable solutions that bridge biodiversity to biomedicine may include the adoption of policies that shift paradigms around “ownership” of nature and the ecosystem services humans enjoy from diverse systems. Here we provide a context for the concept of commodifying ecosystem services as natural resources.",
publisher = "Cambridge (Massachusetts, United States) : Academic Press - Elsevier",
journal = "Biodiversity and Biomedicine: Our Future",
booktitle = "Biomedicine: biodiversity’s panacea? Context of commodification",
doi = "10.1016/B978-0-12-819541-3.00026-8",
pages = "525-537"
}

Johnson, M. V., Shrestha, U. B., Neergheen, V. S., Kagansky, A., Pešić, M.,& Malone, J. H.. (2020). Biomedicine: biodiversity’s panacea? Context of commodification. in Biodiversity and Biomedicine: Our Future
Cambridge (Massachusetts, United States) : Academic Press - Elsevier., 525-537.
https://doi.org/10.1016/B978-0-12-819541-3.00026-8

Johnson MV, Shrestha UB, Neergheen VS, Kagansky A, Pešić M, Malone JH. Biomedicine: biodiversity’s panacea? Context of commodification. in Biodiversity and Biomedicine: Our Future. 2020;:525-537.
doi:10.1016/B978-0-12-819541-3.00026-8 .

Johnson, Mari-Vaughn V., Shrestha, Uttam Babu, Neergheen, Vidushi S., Kagansky, Alexander, Pešić, Milica, Malone, John H., "Biomedicine: biodiversity’s panacea? Context of commodification" in Biodiversity and Biomedicine: Our Future (2020):525-537,
https://doi.org/10.1016/B978-0-12-819541-3.00026-8 . .